Literature DB >> 7202952

Fulminant hepatic failure: an unusual presentation of metastatic liver disease.

H B Harrison, H M Middleton, J H Crosby, M N Dasher.   

Abstract

Over a 2-yr period, 3 patients with metastatic liver disease presented with a clinical course compatible with fulminant hepatic failure. The course was characterized by abdominal pain, jaundice, rapidly deteriorating mental status, high-serum enzyme values (SGOT, LDH, alkaline phosphatase), prolonged prothrombin times, and death within 1-12 days after hospitalization. At autopsy a similar histologic picture was present in each: extensive infiltration and replacement of liver by tumor and widespread infarction of remaining parenchyma. To place these 3 cases into a proper perspective, they were compared with 3 similar, previously reported cases (1 primary and 2 metastatic); and a retrospective autopsy review of metastatic liver disease occurring over a 4-yr period was performed. Fulminant hepatic failure due to extensive parenchymal infarction appears to represent an uncommon, but distinct entity in the overall spectrum of metastatic liver disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7202952

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Primary hepatocellular carcinoma presenting as fulminant hepatic failure in a young woman.

Authors:  L J Levy; L M Swinburne; R P Boulton; M S Losowsky
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

2.  Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy.

Authors:  Yasser M Bhat; Alyssa Krasinskas; Fiona E Craig; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 3.  Fulminant Hepatic Failure Secondary to Metastatic Transitional Cell Carcinoma-Case Report and Review of the Literature.

Authors:  Aijaz Ahmed Sofi; Luis de Las Casas; Zeeshan Tariq; Ali Nawras; Wael Youssef
Journal:  J Gastrointest Cancer       Date:  2012-09

4.  Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.

Authors:  D Rowbotham; J Wendon; R Williams
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

5.  Fulminant hepatic failure resulting from small-cell lung cancer and dramatic response of chemotherapy.

Authors:  Kyoichi Kaira; Atsushi Takise; Rieko Watanabe; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

6.  Fulminant hepatic failure secondary to diffuse liver infiltration by melanoma.

Authors:  P M Bouloux; R J Scott; J E Goligher; C Kindell
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

Review 7.  Acute liver failure due to hepatic involvement by hematologic malignancy.

Authors:  T M Shehab; M S Kaminski; A S Lok
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

8.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

Review 9.  Angiosarcoma of the liver as a cause of fulminant liver failure.

Authors:  Marco Montell García; Raúl Romero Cabello; Raul Romero Feregrino; Mercado Atri Moises; Rafael Trejo Estrada; Padilla-Rodríguez Alvaro; Gama Moreno Manlio Gerardo; Romero Feregrino Rodrigo
Journal:  BMJ Case Rep       Date:  2012-08-02

10.  Acute Liver Failure due to Miliary Liver Metastasis.

Authors:  Charles A Lavender; Jessica Stout; Hui-Yong Chung; Michael Johnson; Ragesh B Thandassery
Journal:  ACG Case Rep J       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.